A multi-cohort genome-wide association study of tau PET, a brain imaging-based marker of Alzheimer’s disease, identifies a CYP1B1-RMDN2 locus as associated with higher tau and faster cognitive decline. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.